Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Quo vadis radiotherapy? Technological advances and the rising problems in cancer managementAllen, B.; Bezak, E.; Marcu, L.
2006The prediction of transmitted dose distributions using a 3D treatment planning systemReich, P.; Bezak, E.; Mohammadi, M.; Fog, L.
2013Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of diseaseWeekley, C.; Harris, H.
2011Uptake, distribution, and speciation of selenoamino acids by human cancer cells: X-ray absorption and fluorescence methodsWeekley, C.; Aitken, J.; Vogt, S.; Finney, L.; Paterson, D.; De Jonge, M.; Howard, D.; Musgrave, I.; Harris, H.
2005Tumour resistance to cisplatin: a modelling approachMarcu, L.; Bezak, E.; Olver, I.; Van Doorn, T.
2011Gallium-68 Complex of a Macrobicyclic Cage Amine Chelator Tethered to Two Integrin-Targeting Peptides for Diagnostic Tumor ImagingMa, M.; Neels, O.; Denoyer, D.; Roselt, P.; Karas, J.; Scanlon, D.; White, J.; Hicks, R.; Donnelly, P.
2012In silico modelling of treatment-induced tumour cell kill: Developments and advancesMarcu, L.; Harriss-Phillips, W.
2012In silico modelling of tumour margin diffusion and infiltration: Review of current statusMoghaddasi, F.; Bezak, E.; Marcu, L.
2012Current challenges in clinical target volume definition: tumour margins and microscopic extensionsMoghaddasi, F.; Bezak, E.; Marcu, L.
2014High mitochondrial accumulation of new gadolinium(III) agents within tumour cellsMorrison, D.; Aitken, J.; De Jonge, M.; Ioppolo, J.; Harris, H.; Rendina, L.